Yankees To Re-Sign Jonathan Loáisiga

The Yankees have agreed to a one-year deal with right-handed reliever Jonathan Loáisiga, reports Jorge Castillo of ESPN. The deal includes a team option for the 2026 season. Financial details have not yet been revealed. While Loáisiga’s health is a concern after he underwent internal brace surgery this past April, Castillo notes that he is on track to get back on the mound in late April 2025. Levi Luna (X link) was the first to report that the two sides were nearing a deal. 

Loáisiga, 30, began his professional career with the Giants, signing as an international free agent in 2012. Unfortunately, he struggled with injuries, and the Giants released him partway through the 2015 season. The Yankees scooped him up in 2016, but it wasn’t long before his injury troubles came back. He suffered a torn UCL, and Tommy John surgery kept him off the field until June 2017. Yet, he was sensational upon his return, pitching to a 1.38 ERA and 2.17 FIP in 32.2 innings between Rookie Ball and Low-A. It was enough for MLB Pipeline, FanGraphs, and Baseball America to rank him among the top 25 prospects in New York’s farm system entering 2018. After another strong showing that year, he shot up to the no. 2 spot on all three lists.

Success eluded Loáisiga at the big league level over his first three seasons from 2018-20. It didn’t help that various injuries plagued him during that time, most notably a shoulder strain in 2019. However, things changed when the righty moved into a full-time relief role in 2021. He continued to deal with shoulder problems (he spent most of September on the IL), but when he was on the field, he was one of the best relievers in the sport. Loáisiga pitched to a 2.17 ERA and 3.01 SIERA over 70 2/3 innings. His sinker, which was suddenly touching triple-digits, became his new primary pitch, and he paired it with a new-look curveball that was practically unhittable. Meanwhile, his changeup was his strongest weapon against opposite-handed hitters, and it helped him post almost equally impressive numbers against righties and lefties alike.

Sadly, Loáisiga has yet to pitch a full season since his 2021 breakout. His shoulder gave him trouble once again in 2022, while his elbow problems returned the following season. He had surgery to address bone spurs in his elbow in April 2023 and internal brace surgery to repair a torn UCL in April 2024. He has only pitched 69 2/3 innings over the past three years, putting up a 3.62 ERA and 3.91 SIERA. Yet, he still has plenty of promise in his powerful right arm. He averaged 98 mph on his sinker over three appearances this past April, and the handful of curveballs he threw still looked filthy. That explains why several teams expressed interest in signing him this winter, including the Padres, Rangers, Mets, and Blue Jays.

It’s also a promising sign that the team that knows him (and his injury history) best is the team that ultimately re-signed him. Unlike some of Loáisiga’s other suitors (namely the Padres and Rangers), the Yankees don’t need to hunt for bargains or bet on buy-low free agent targets. They just signed Max Fried to a massive eight-year deal, and they’re not done looking for upgrades as they try to replace Juan Soto in the aggregate. They wouldn’t have signed Loáisiga if they didn’t think he could be a valuable contributor to their bullpen.

The Yankees lost several relievers to free agency this offseason, including Clay Holmes, Tommy Kahnle, and Tim Hill. Thus, Loáisiga will slot into a ’pen that lacks high-leverage arms after Luke Weaver and Ian Hamilton. General manager Brian Cashman will presumably remain active in the market for relievers; the Yankees were linked to All-Star closer Carlos Estévez earlier this offseason, while reunions with Kahnle and Hill could also be in the cards.